Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we would like to inform you that a meeting of Board of Directors of was held today i.e August 31, 2026 at the registered office of the Company.
Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Filed with BSE · · 6 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 24 2026
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 07 2026
Later from Venmax Drugs & Pharmaceuticals
- Reg. 34 (1) Annual Report.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 01 2026
- Announcement under Regulation 30 (LODR)-Scheme of Arrangement
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 08 2026
- Closure of Trading Window
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals